Histiocytosis Program

Quick Links

Why Choose Care for Histiocytosis At Monroe Carell

The Histiocytosis Program at Monroe Carell and Vanderbilt University Hospital offers comprehensive diagnostic, consultative and therapeutic services for children with histiocytic disorders. These disorders can affect any part of the body. They include Langerhans cell histiocytosis (LCH; also known as eosinophilic granuloma or histiocytosis X), hemophagocytic lymphohistiocytosis (HLH), Rosai-Dorfman disease (RDD; also known as sinus histiocytosis with massive lymphadenopathy), juvenile xanthogranuloma (JXG) and other less common histiocytic disorders.

Monroe Carell provides consultations for patients with newly diagnosed or recurrent histiocytosis. We also offer individualized treatment plans for patients with newly diagnosed or recurrent histiocytosis, and we participate in international clinical trials conducted by the Histiocyte Society.

Conditions We Treat

We treat all conditions related to pediatric histiocytosis, including:

Hemophagocytic lymphohistiocytosis (HLH)
Juvenile xanthogranuloma (JXG)
Langerhans cell histiocytosis (LCH)
Rosai-Dorfman disease (RDD)

Meet Your Care Team

Debra L. FriedmanMD, MS

Division of Pediatric Hematology/Oncology,

General Hematology and Oncology,

Leukemia and Lymphoma,

Pediatric Hematology/Oncology,

Solid Organ Malignancies

Why Choose Care for Histiocytosis At Monroe Carell

Collaborative care
Our physicians collaborate with experts around the nation through the Children’s Oncology Group and the Histiocyte Society to bring the latest treatments and clinical trial options.
Personalized care
We offer a personalized approach to your child’s care through the collaboration of experts from oncology, ophthalmology, orthopedics, radiation oncology, surgery, neurosurgery, nursing, child life, social work, psychology, physical and occupational therapy and nutrition.
Recognized care
U.S. News & World Report has ranked Monroe Carell as one of the best pediatric cancer programs in the nation.